Menu by Therapeutic Area:
Select
All
Oncology Biomarkers
Inflammation Biomarkers
Cardiovascular Biomarkers
Diabetes/Obesity Biomarkers
Pulmonary Disease Biomarkers
Neurological Disease Biomarkers
Vascular Injury Biomarkers
Menu by Research Area:
Select
All
Angiogenesis Factors Biomarkers
Cell Adhesion Molecules Biomarkers
Chemokines Biomarkers
Cytokines Biomarkers
Cytokine Receptor Biomarkers
Growth Factors Biomarkers
Immunoglobulins Biomarkers
Matrix Metalloproteinases Biomarkers
Neurotrophic Factors Biomarkers
Company
Products & Services
Support
Resource Center
Events
Contact Us
Lunch & Learn Oncology Biomarker Seminars in San Diego and Cambridge: Register Today
7/27/11 MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility. Additional 2470 will meet increased demand from MD Anderson researchers and other core facility clients for increased RPPA data
6/10/11 Aushon's Multiplex Immunoassay Platform Used to Validate Panel of Prognostic and Predictive Protein Biomarkers in Recent Phase II and Phase III Studies
4/5/11 Aushon Launches New SignaturePLUS™ System for Multiplex Protein Biomarker Analysis
2/8/11 Aushon BioSystems and Peking University Cancer Hospital Collaboration to Focus on Predictive Diagnostic Biomarkers for Liver Metastases of Colorectal Cancer
11/30/10 Aushon BioSystems and LightArray Partner to Offer Protein Biomarker Testing Services and Products in China
